4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-022460
CHIEF OPERATING OFFICER sold 16,200 shares at an average $33.77 ($547,141)
- CHIEF OPERATING OFFICER acquired 6,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-18 | Option exercise 10b5-1 | +6,500 | $8.83 | $57,395 | 56,415 | D: show line 1 in the form |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-18 | Sale 10b5-1 | −16,100 | $33.77 | $543,697 | 40,315 | D: show line 2 in the form |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-18 | Sale 10b5-1 | −100 | $34.44 | $3,444 | 40,215 | D: show line 3 in the form |
| Open-market sales · 16,200 sh · avg $33.77 · $547,141 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-08-18 | Option exercise · Share Option 10b5-1 | −6,500 | 25,500 | D: show line 4 in the form |
Loading xslF345X05/form4-08202025_080850.xml…